Beyond its work at the EU level, the BEAM Alliance also interacts with national stakeholders, both within and outside the EU. The aim is to encourage EU Member States to actively contribute to exchanges on AMR in the co-legislative process and for every state to put in place their own plan to combat AMR, in particular by supporting innovation.
To achieve this, BEAM relies on a network of National Coordinators among its members, whose role is to carry the voice of SMEs by adapting it to the national context. These different National Coordinators are listed below.
AUSTRIA
BioNTech R&D: Alexander Belcredi
BELGIUM
Santero Tx: Cédric Govaerts
DENMARK
Disperazol: Michael Graz
FINLAND
Arivin:Chris Jonkergouw
FRANCE
AUROBAC Tx: Florence Séjourné
ANTABIO: Marc Lemonnier
GERMANY
BioVersys: Marc Gitzinger
HYpharm: Ingrid Wanninger
ICELAND
Akthelia: Egill Masson
IRELAND
Assuré Medical: Ger Okeeffe
ISRAEL
Omnix Medical: Niv Bachnoff
ITALY
F2G: Daniela Zinzi
PORTUGAL
Immunethep: Bruno Santos
SPAIN
ABAC Tx: Domingo Gargallo-Viola
SWEDEN
APL: Helén Fält
SWITZERLAND
Debiopharm: Morgane Vanbiervliet
BioVersys: Marc Gitzinger
NETHERLANDS
SurvivX: Remko Van Leeuwen
UK
Infex Tx: Pete Jackson